
-

Laser Treatments Developed for Age-Related Vision Loss
Researchers in Finland are designing techniques using temperature-controlled lasers to treat a common form of vision loss associated with aging.
-

Sanofi, Alphabet Partner on A.I., Analytics
Drug maker Sanofi and Alphabet, the parent company of Google, are collaborating on the use of artificial intelligence and analytics for more personalized health care.
-

Challenge Seeks Circular Economy Start-Ups
A challenge competition is seeking new businesses that disrupt the plastics recycling and energy storage industries with ideas based on a circular economy.
-

Topical Immune Drug Reverses Skin Disease
A drug targeting immune system enzymes used as a skin cream is shown in a clinical trial to reverse effects of vitiligo, or loss of skin coloring.
-

A.I. Harnessed to Diagnose Children’s Gut Diseases
Medical researchers and data scientists are using artificial intelligence, or A.I., to diagnose children’s intestinal diseases found in the developing world.
-

Efficient Carbon Capture Membranes Being Developed
University engineers and chemists are creating a more efficient material for separating carbon dioxide from emissions in power and industrial plants.
-

Infographic – Phones Top Internet Access Method
Findings from a Pew Research Center survey released this week show more Americans with smartphones use their phones to access the Internet than other methods, this weekend’s infographic.
-

Nerve Stimulation Reduces Arthritis Inflammation
Results from a small-scale clinical trial show an implanted device that stimulates the vagus nerve helps reduce the activity of rheumatoid arthritis.
-

Gates Funding VR with Expansion Microscopes
The Bill and Melinda Gates Foundation is backing research to combine a microscopy technique that grows the size of samples being examined with virtual reality, or VR.
-

Chip Device Simulates Blood-Brain Barrier
A bioengineering lab developed a miniaturized chip with living cells that offers a realistic simulation of the blood-brain barrier to test new drugs.